One of Cimav’s goals is to research how nanoparticles affect biomedical implants and then apply that knowledge in real-world settings. Scientists there are currently pairing bone tissue with novel material fabrication to do just that.
They’ve currently found new uses for hydroxyapatite, a major component of normal human bone, by adding nanoparticles to its matrix. The final result has been the improvement of the materials’ biocompatibility.
To date, the Cimav team has published more than nine papers related to this variety of research.
For more orthopedic news:
12 orthopedic surgeons in the headlines this week — Jan. 9
Dr. Tad Gerlinger’s study: Knee replacement surgery effective for soldiers
TKA patients likely to suffer worsening of OA symptoms, study finds
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.